Company · CIK 0001344413 · SIC 2834 — Pharmaceutical Preparations
Alexza Pharmaceuticals Inc. · ALXA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2016 PForm 4 → | Jun 22, 3:12 pm EDT | Grupo Ferrer Internacional, S.A. +110% Owner | 19,465,714 | $0.90 | $17,519,143 | 21,832,649 | +822% | plan? |
| Jun 21, 2016 UForm 4 → | Jun 21, 3:56 pm EDT | Edwin S KamemotoEVP, R&D, Regulatory & Quality | 9,112 | — | — | 0 | — | plan? |
| Jun 21, 2016 UForm 4 → | Jun 21, 3:54 pm EDT | Thomas Braxton KingPresident & CEO, Director | 77,224 | — | — | 0 | — | plan? |
| Jun 21, 2016 UForm 4 → | Jun 21, 3:52 pm EDT | Joseph L TurnerDirector | 1,050 | — | — | 0 | — | plan? |
| Jun 21, 2016 UForm 4 → | Jun 21, 3:50 pm EDT | Isaac SteinDirector | 15,838 | — | — | 0 | — | plan? |
| Jun 21, 2016 UForm 4 → | Jun 21, 3:47 pm EDT | Gordon RingoldDirector | 34,246 | — | — | 0 | — | plan? |
| Jun 21, 2016 UForm 4 → | Jun 21, 3:45 pm EDT | J Leighton ReadDirector | 3,492 | — | — | 0 | — | plan? |
| Jun 21, 2016 UForm 4 → | Jun 21, 3:42 pm EDT | Deepika PakianathanDirector | 99,625 | — | — | 0 | — | plan? |
| Sep 28, 2015 PForm 4/A → | Mar 3, 2016, 10:16 am EST | Grupo Ferrer Internacional, S.A. +110% Owner | 125,000 | — | — | 2,366,935 | — | plan? |
| Sep 28, 2015 PForm 4 → | Sep 28, 5:10 pm EDT | Grupo Ferrer Internacional, S.A.10% Owner | 125,000 | — | — | 2,366,935 | — | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2016 DForm 4 → | Jun 21, 3:56 pm EDT | Edwin S KamemotoEVP, R&D, Regulatory & Quality | 257,749 | — | — | 0 | — | |
| Jun 21, 2016 DForm 4 → | Jun 21, 3:54 pm EDT | Thomas Braxton KingPresident & CEO, Director | 574,219 | — | — | 0 | — | |
| Jun 21, 2016 DForm 4 → | Jun 21, 3:52 pm EDT | Joseph L TurnerDirector | 46,222 | — | — | 0 | — | |
| Jun 21, 2016 DForm 4 → | Jun 21, 3:50 pm EDT | Isaac SteinDirector | 46,222 | — | — | 0 | — | |
| Jun 21, 2016 DForm 4 → | Jun 21, 3:47 pm EDT | Gordon RingoldDirector | 46,222 | — | — | 0 | — | |
| Jun 21, 2016 DForm 4 → | Jun 21, 3:45 pm EDT | J Leighton ReadDirector | 46,222 | — | — | 0 | — | |
| Jun 21, 2016 DForm 4 → | Jun 21, 3:42 pm EDT | Deepika PakianathanDirector | 46,222 | — | — | 0 | — | |
| Jun 21, 2016 DForm 4 → | Jun 21, 3:40 pm EDT | J Kevin BuchiDirector | 45,000 | — | — | 0 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 4:40 pm EDT | Edwin S KamemotoEVP, R&D and Quality | 125,000 | — | — | 125,000 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 4:39 pm EDT | Mark K OkiSVP, Finance, CFO & Sec | 125,000 | — | — | 125,000 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 4:37 pm EDT | Thomas Braxton KingPresident and CEO, Director | 400,000 | — | — | 400,000 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 4:35 pm EDT | Isaac SteinDirector | 12,500 | — | — | 12,500 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 4:32 pm EDT | Deepika PakianathanDirector | 12,500 | — | — | 12,500 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 4:28 pm EDT | J Leighton ReadDirector | 12,500 | — | — | 12,500 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 4:28 pm EDT | J Kevin BuchiDirector | 12,500 | — | — | 12,500 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 4:27 pm EDT | Joseph L TurnerDirector | 12,500 | — | — | 12,500 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 4:26 pm EDT | Gordon RingoldDirector | 12,500 | — | — | 12,500 | — | |
| Apr 28, 2015 AForm 4 → | Apr 29, 4:51 pm EDT | Edwin S KamemotoEVP, R&D and Quality | 35,000 | — | — | 35,000 | — | amended |